Literature DB >> 8527474

A plasmid-based self-amplifying Sindbis virus vector.

H Herweijer1, J S Latendresse, P Williams, G Zhang, I Danko, S Schlesinger, J A Wolff.   

Abstract

Sindbis virus was used as a self-amplifying eukaryotic expression vector. A recombinant cDNA genome of this (+)-strand RNA virus was placed under the transcriptional control of a Rous sarcoma virus LTR (RSV) promoter. Transfection of this plasmid construct into mammalian cell lines (3T3, HepG2, and 293 cells) resulted in expression of the luciferase reporter gene. High-expression levels were also measured after transfection into primary rat myoblasts. In differentiated myotubes, expression levels generated by the Sindbis virus vector were up to 200 times higher than those obtained with a conventional RSV expression vector. In vivo expression was detected after injection of plasmid DNA into mouse quadriceps. In vivo expression was transient and undetectable by day 16. This self-amplifying expression vector can be used for generating high-level expression of transgenes in vitro and in vivo. Its transient nature in vivo could allow for safe, short-term delivery of gene products in gene therapy protocols. It should facilitate the study of Sindbis and other RNA viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527474     DOI: 10.1089/hum.1995.6.9-1161

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  25 in total

1.  Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.

Authors:  J M Polo; B A Belli; D A Driver; I Frolov; S Sherrill; M J Hariharan; K Townsend; S Perri; S J Mento; D J Jolly; S M Chang; S Schlesinger; T W Dubensky
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 2.  Virus-based gene delivery systems.

Authors:  Cathryn Mah; Barry J Byrne; Terence R Flotte
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

Authors:  Wolfgang W Leitner; Leroy N Hwang; Elke S Bergmann-Leitner; Steven E Finkelstein; Stephan Frank; Nicholas P Restifo
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

4.  Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.

Authors:  G Ward; E Rieder; P W Mason
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA.

Authors:  I Frolov; E Frolova; S Schlesinger
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 6.  Vectorology and factor delivery in induced pluripotent stem cell reprogramming.

Authors:  Kejin Hu
Journal:  Stem Cells Dev       Date:  2014-04-16       Impact factor: 3.272

Review 7.  Alphavirus-based expression vectors: strategies and applications.

Authors:  I Frolov; T A Hoffman; B M Prágai; S A Dryga; H V Huang; S Schlesinger; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 8.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Authors:  Chien-Hsiung Pan; Nitya Nair; Robert J Adams; M Christine Zink; Eun-Young Lee; Fernando P Polack; Manmohan Singh; Derek T O'Hagan; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

10.  Regulated expression of a Sindbis virus replicon by herpesvirus promoters.

Authors:  L Ivanova; S Schlesinger; P D Olivo
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.